Quattro Financial Advisors LLC Atai Life Sciences N.V. Transaction History

Quattro Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$1.5 - $2.19 $106,464 - $155,437	70,976 New	70,976 $139,000
Q3 2022 Oct 24, 2022	BUY	$3.14 - $4.87 $55,364 - $85,867	17,632 Added 33.05%	70,976 $235,000
Q2 2022 Aug 01, 2022	BUY	$3.03 - $5.32 $161,632 - $283,790	53,344 New	53,344 $194,000
Q1 2022 Apr 22, 2022	SELL	$4.66 - $7.66 $248,583 - $408,615	-53,344 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$6.82 - $17.8 $363,806 - $949,523	53,344 New	53,344 $407,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Quattro Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Quattro Financial Advisors LLC with notifications on news.